HER2 Expression in Gastric and Gastroesophageal Junction Adenocarcinoma in a US Population

HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population

BACKGROUND With varied immunohistochemistry scoring criteria and patient cohorts, HER2-positivity rates in gastric cancer (GC) and gastroesophageal junction (GEJ) adenocarcinoma have been reported with a wide range. Recently standardized scoring criteria for GC and GEJ cancer has been established and recommended. In this study, the frequency of HER2 expression and the relationship between HER2 ...

HER2/neu Expression in Gastric and Esophagogastric Junction Adenocarcinoma

Background: Gastric cancer is one of the most commonly diagnosed cancer and one of the most common causes of cancerrelated deaths worldwide. HER-2/neu, a well-recognized factor, is indicated in the development of certain human solid tumors, notably breast cancer. High expression of HER2/neu has correlated with poor prognosis. Studies reveal combination of treatment with antibody targeting HER-2...

Incidence of brain metastases in HER2+ gastric or gastroesophageal junction adenocarcinoma.

Isolated Splenic Metastases of Her2+++ Gastroesophageal Junction Adenocarcinoma

Isolated metastases from gastric adenocarcinoma to the spleen are very infrequent. Usually, there are multiple metastases from gastric cancer, and isolated splenic metastases are very rare [Lam and Tang: Arch Pathol Lab Med 2000;124:526-530] because of certain anatomical and physiological characteristics (e.g., angulation between the splenic artery and celiac trunk, paucity of afferent lymph fl...

characteristics and survival rate of patients with gastric and gastroesophageal junction adenocarcinoma in yazd, iran

background: gastric cancer is the leading cause of cancer deaths in iran. treatment for gastric adenocarcinoma varies worldwide. the aim of this study is to evaluate char- acteristics and survival rate of gastric and gastroesophageal junction adenocarcinoma in yazd, iran. methods: this study was conducted on 53 patients with gastric or gastroesophageal junction adenocarcioma who referred to sha...